Skip to contentI
Inspire Medical Systems, Inc.
I
INSPInspire Medical Systems, Inc. Q1 2021 · 10-Q
Revenue$40.35M$40.35M+89.0% vs Q1 2020 Net Income-$16.22M-$16.22MN/M vs Q1 2020 EPS Diluted-$0.60-$0.60N/M vs Q1 2020 Gross Profit$34,371,000+90.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inspire Medical Systems, Inc. · CIK 1609550 · Engraved from SEC EDGAR
Operating Cash Flow-$10,401,000N/M Free Cash Flowderived-$11,722,000N/M Margins · derivedGross margin85.2%+0.6 pt vs Q1 2020
Operating margin-38.9%+38.1 pt vs Q1 2020
Net margin-40.2%+35.9 pt vs Q1 2020
ended Mar 31, 2021 · filed May 4, 2021 · 34 d after period end